XML 28 R19.htm IDEA: XBRL DOCUMENT
v3.25.3

Revenue from Contracts with Customers | 9 Months Ended
--- | ---
Sep. 30, 2025
Collaboration [Abstract] |
Revenue from Contracts with Customers | Note K – Revenue from Contracts with Customers Disaggregation of Revenue The following table presents revenue (in thousands) for the three and nine months ended September 30, 2025 and 2024, disaggregated by geographic region and revenue type. Revenue by geographic region is allocated based on the domicile of our respective business operations.
|  | Three months ended September 30, 2025 |
|  | United States |  |  | Rest of World |  |  | Total |
Revenue Type |  |  |  |  |  |  |  |  |
Clinical product revenue |  | $ | 1,087 |  |  | $ | — |  |  | $ | 1,087 |
Other services |  |  | — |  |  |  | — |  |  |  | — |
Non-cash royalties |  |  | 29,148 |  |  |  | — |  |  |  | 29,148 |
|  | $ | 30,235 |  |  | $ | — |  |  | $ | 30,235 |
|  | Three months ended September 30, 2024 |
Revenue Type |  |  |  |  |  |  |  |  |
Other services |  | $ | — |  |  | $ | 454 |  |  | $ | 454 |
Non-cash royalties |  |  | 24,658 |  |  |  | — |  |  |  | 24,658 |
|  | $ | 24,658 |  |  | $ | 454 |  |  | $ | 25,112 |
|  | Nine months ended September 30, 2025 |
|  | United States |  |  | Rest of World |  |  | Total |
Revenue Type |  |  |  |  |  |  |  |  |
Clinical product revenue |  | $ | 1,421 |  |  | $ | — |  |  | $ | 1,421 |
Other services |  |  | — |  |  |  | 1,036 |  |  |  | 1,036 |
Non-cash royalties |  |  | 77,535 |  |  |  | — |  |  |  | 77,535 |
|  | $ | 78,956 |  |  | $ | 1,036 |  |  | $ | 79,992 |
|  | Nine months ended September 30, 2024 |
Revenue Type |  |  |  |  |  |  |  |  |
Clinical product revenue |  | $ | 267 |  |  | $ | — |  |  | $ | 267 |
Other services |  |  | — |  |  |  | 1,353 |  |  |  | 1,353 |
Non-cash royalties |  |  | 75,006 |  |  |  | — |  |  |  | 75,006 |
|  | $ | 75,273 |  |  | $ | 1,353 |  |  | $ | 76,626 |
Contract Balances Contract assets primarily relate to our rights to consideration for work completed in relation to our research and development services performed but not billed at the reporting date. The contract assets are transferred to receivables when the rights become unconditional. Currently, we do not have any contract assets which have not transferred to a receivable. We had no asset impairment charges related to contract assets in the period. Contract liabilities primarily relate to contracts where we received payments but have not yet satisfied the related performance obligations. The advance consideration received from customers for research and development services or licenses bundled with other promises is a contract liability until the underlying performance obligations are transferred to the customer. The following table provides information about contract liabilities from contracts with customers (in thousands):
Nine months ended September 30, 2025 |  | Balance at beginning of period |  |  | Additions |  |  | Deductions |  |  | Balance at end of period |
Contract liabilities: |  |  |  |  |  |  |  |  |  |  |  |
Deferred revenue |  | $ | 1,174 |  |  | $ | 45 |  |  | $ | (31 | ) |  | $ | 1,188 |
During the nine months ended September 30, 2025, we did not recognize any revenue from amounts included in the contract asset or the contract liability balances from performance obligations satisfied in previous periods. No ne of the costs to obtain or fulfill a contract were capitalized.

X
- Definition Collaboration. + References No definition available. + Details
Name: | agen_CollaborationAbstract
Namespace Prefix: | agen_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-7 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-9 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 15 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-15 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-13 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Name Accounting Standards Codification -Topic 606 -Publisher FASB -URI https://asc.fasb.org/606/tableOfContent + Details
Name: | us-gaap_RevenueFromContractWithCustomerTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration